Lisa Werr
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.
Journal: The Journal of clinical investigation
Published: February 12, 2026
Neuronal differentiation of neuroblastoma cell lines for neurological disease modeling.
Journal: iScience
Published: December 28, 2025
Publisher Correction: Functional synapses between neurons and small cell lung cancer.
Journal: Nature
Published: September 19, 2025
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.
Journal: The Journal of clinical investigation
Published: November 25, 2024
TERT Expression and Clinical Outcome in Pulmonary Carcinoids.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2024
Evolutionary trajectories of small cell lung cancer under therapy.
Journal: Nature
Published: January 25, 2023
Functional synapses between neurons and small cell lung cancer.
Journal: Nature
Published: December 20, 2022
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 03, 2022
Reliable assessment of telomere maintenance mechanisms in neuroblastoma.
Journal: Cell & bioscience
Published: May 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 29, 2022
Last Updated: 09/26/2026